Medarex, Inc

Article Abstract:

The shares of Medarex Inc. have good price appreciation potential over the 2010-2012 timeframe. The Princeton, New Jersey-based company is engaged in the development of pharmaceutical products using its patented human monoclonal antibody production technology.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Medarex Inc

Article Abstract:

A comparative analysis of the company sales and earnings and the financial details of Medarex Inc. from 1994 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Medarex Inc

Article Abstract:

Medarex has cash but it would hardly be enough to cover rising research and development costs and the convertible notes that expire in 2006. Issue is untimely and only risk-tolerant investors should commit.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: